EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thromboinflammatory Biomarkers in Lymphomas: Linking Inflammation to Thrombosis Risk

Emilija Živković iD, Olivera Mitrović-Ajtić iD, Tijana Subotički iD, Jelena Ivanović iD, Vladimir Otašević iD, Dragoslava Đikić, Miloš Diklić iD, Milica Vukotić iD, Teodora Dragojević iD, Dejana Stanisavljević, Darko Antić iD, Vladan P Čokić iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26052058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Emilija Živković und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Thrombosis, Lymphoma, Inflammation, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study is supported by the Science Fund of the Republic of Serbia, within the IDEAS projects. Acronym: EPOCHAL, No. 7749695, Science Fund of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombosis is a critical complication in lymphomas, driven by chronic inflammation. To observe this systemic mechanism, we evaluated inflammatory cytokines, neutrophil and monocyte activation, and platelet function in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and Hodgkin lymphoma (HL), with and without thrombosis using ELISA and flow cytometry according to laboratory and clinical data. Interleukin-1β was elevated across lymphomas and inversely correlated with the Khorana score for venous thromboembolism, while increased tumor necrosis factor-alpha (TNF-α) was inversely associated with the International Prognostic Index (IPI) in thrombosis-associated lymphomas. Neutrophil activation was increased in DLBCL, while elevated neutrophil extracellular traps (NETs) biomarkers were inversely consistent with thrombosis and the ThroLy score. NETs were elevated in HL. Classical monocytes were increased in all lymphoma subtypes, with intermediate and tissue factor (TF)-carrying monocytes elevated in DLBCL and HL. Platelet activation was pronounced, with platelet–monocyte aggregates and platelet-associated TF elevated in DLBCL and FL but not HL. P-selectin was increased in lymphomas with thrombosis, aligned with Khorana and ThroLy scores, and reflected clinical stage while inversely correlating with IPI in non-thrombotic lymphomas. These findings highlight distinct thromboinflammatory mechanisms across lymphoma subtypes, providing insights into biomarkers for thrombosis risk and therapeutic targets in lymphoma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisLymphomaInflammationBiomarkers, TumorThromboinflammationHumansMaleFemaleBiomarkersMiddle AgedPlatelet ActivationMonocytesExtracellular TrapsNeutrophilsHodgkin DiseaseBlood PlateletsLymphoma, Large B-Cell, DiffuseAgedAdultCytokinesLymphoma, Follicular

Stichwörter der Autor:innen

Hodgkin lymphomacytokinesinflammationnon-Hodgkin lymphomathrombosis

Substanzen

BiomarkersBiomarkers, TumorCytokines

Autor:innen und Institutionen

  • Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
  • Lymphoma Center, Clinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  • Parexel International, Durham, NC 27713, USA.
  • Institute for Medical Statistics and Informatics, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

ORCID-Profile: Emilija Živković, Olivera Mitrović-Ajtić, Tijana Subotički, Jelena Ivanović, Vladimir Otašević, Miloš Diklić, Milica Vukotić, Teodora Dragojević, Darko Antić, Vladan P Čokić

Förderung

  • This study is supported by the Science Fund of the Republic of Serbia, within the IDEAS projects. Acronym: EPOCHAL, No. 7749695
  • Science Fund of the Republic of Serbia

Zitieren

APA

Živković, E., Mitrović-Ajtić, O., Subotički, T., Ivanović, J., Otašević, V., Đikić, D., Diklić, M., Vukotić, M., Dragojević, T., Stanisavljević, D., Antić, D., & Čokić, V. P. (2025). Thromboinflammatory Biomarkers in Lymphomas: Linking Inflammation to Thrombosis Risk. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052058

Vancouver

Živković E, Mitrović-Ajtić O, Subotički T, Ivanović J, Otašević V, Đikić D, et al. Thromboinflammatory Biomarkers in Lymphomas: Linking Inflammation to Thrombosis Risk. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052058

BibTeX
@article{ivkovi2025,
  author = {Živković, Emilija and Mitrović-Ajtić, Olivera and Subotički, Tijana and Ivanović, Jelena and Otašević, Vladimir and Đikić, Dragoslava and Diklić, Miloš and Vukotić, Milica and Dragojević, Teodora and Stanisavljević, Dejana and Antić, Darko and Čokić, Vladan P},
  title = {Thromboinflammatory Biomarkers in Lymphomas: Linking Inflammation to Thrombosis Risk},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26052058}
}
Kostenlos starten →